PPH

VanEck announced today the following 2024 annual distributions per share for its VanEck® equity exchange-traded funds. Distributions Per Share for the VanEck ETFs Listed Below Ex-Date: December 23, 2024 | Record Date: December 23, 2024 | Payable Date: December 24, 2024 Fund Ticker   Income Approximate % of Income from PFICs Short-Term Capital Gain Long-Term Capital Gain VanEck Africa Index ETF AFK None None None None VanEck Biotech ETF BBH $ 1.2517 22% None None VanEck Gaming ETF BJK $ 1.1667 34% None None VanEck Brazil Small-Cap

Pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) is reportedly set to overtake Denmark’s iconic toymaker, Lego A/S, as the nation’s most valuable brand. For now, Lego continues to hold the title of the nation’s most valuable brand, a position it has maintained for nine consecutive years. However, the pharmaceutical giant is rapidly gaining ground, thanks to the surging popularity of its weight-loss drugs on a global scale. Lego’s brand value has modestly increased by 3% in the past year, reaching approximately $8 billion. In contrast, Novo Nordisk’s brand value soared by 59% to $5.1 billion, reported Bloomberg, citing the latest 2024 country rankings by Brand Finance, released on We

Novo Nordisk A/S (NYSE:NVO)’s Wegovy garnered the Food and Drug Administration’s approval for expanded use Friday, marking what the drugmaker said is a pivotal turn in the treatment landscape for individuals grappling with the dual challenges of obesity and established cardiovascular disease. This approval underscores a new era in preventive health strategies, targeting a significant reduction in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attacks (myocardial infarction) and nonfatal strokes. Leap Forward In Cardiovascular, Weight Management Therapy The FDA’s green light is anchored in the evidence from the SELECT cardiovascular outcom

While many of the world’s investors remain focused on "The Magnificent Seven" — a group of tech stocks that significantly outperformed in 2023 — a small group of European stocks has quietly outperformed most of the world. Based on the first letters of their names, Goldman Sachs dubbed this group “Granolas,” and it accounted for 50% of gains of the Stoxx Europe 600 Index for the past year. Who are the Granolas? Granolas refers to a group of 11 European stocks operating in the healthcare and pharmaceutical sector, with an addition of luxury, consumer staples, industrial manufacturing and software technology. They include: GSK plc (NYSE:GSK): The pharmaceutical company, founded in